Back
Jasper Therapeutics Stock Price Chart
How to hack a $1.3T market
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa
Sell
39
JSPR
Jasper Therapeutics
Last Price:
$5.14
Seasonality Move:
-17.15%
7 Day Trial
ALL ACCESS PASS
$
7
Notable investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa-
The current trend is moderately bullish and JSPR is experiencing slight selling pressure.
Jasper Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.5 | Sell |
| 20-day SMA: | 5.48 | Sell |
| 50-day SMA: | 4.98 | Buy |
| 200-day SMA: | 12.25 | Sell |
| 8-day EMA: | 5.17 | Sell |
| 20-day EMA: | 3.88 | Buy |
| 50-day EMA: | 2.14 | Buy |
| 200-day EMA: | 0.64 | Buy |
Jasper Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.4 | Buy |
| Relative Strength Index (14 RSI): | 45.06 | Sell |
| Chaikin Money Flow: | -74987 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.97 - 5.77) | Sell |
| Bollinger Bands (100): | (4.48 - 5.94) | Sell |
Jasper Therapeutics Technical Analysis
| Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Jasper Therapeutics Stock
Is Jasper Therapeutics Stock a Buy?
-
Jasper Therapeutics share price is 5.15 while JSPR 8-day simple moving average is 5.50, which is a Sell signal.
-
The stock price of JSPR is 5.15 while Jasper Therapeutics 20-day SMA is 5.48, which makes it a Sell.
-
Jasper Therapeutics 50-day simple moving average is 4.98 while JSPR share price is 5.15, making it a Buy technically.
-
JSPR stock price is 5.15 and Jasper Therapeutics 200-day simple moving average is 12.25, creating a Sell signal.
JSPR Technical Analysis vs Fundamental Analysis
Sell
39
Jasper Therapeutics (JSPR)
is a Sell
Is Jasper Therapeutics a Buy or a Sell?
-
Jasper Therapeutics stock is rated a SellThe current Jasper Therapeutics [JSPR] share price is $5.15. The Score for JSPR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
Jasper Therapeutics Stock Info
Market Cap:
77.4M
Price in USD:
5.15
Share Volume:
185.6K
Jasper Therapeutics 52-Week Range
52-Week High:
26.05
52-Week Low:
3.13
Sell
39
Jasper Therapeutics (JSPR)
is a Sell
Jasper Therapeutics Share Price Forecast
-
What is the Jasper Therapeutics stock price today?The Jasper Therapeutics stock price is 5.15 USD today.
-
Will JSPR stock go up or go down?Jasper Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Jasper Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Jasper Therapeutics is overvalued.
Is Jasper Therapeutics Stock a Buy?
-
Jasper Therapeutics share price is 5.15 while JSPR 8-day exponential moving average is 5.17, which is a Sell signal.
-
The stock price of JSPR is 5.15 while Jasper Therapeutics 20-day EMA is 3.88, which makes it a Buy.
-
Jasper Therapeutics 50-day exponential moving average is 2.14 while JSPR share price is 5.15, making it a Buy technically.
-
JSPR stock price is 5.15 and Jasper Therapeutics 200-day simple moving average is 0.64, creating a Buy signal.
Fundamental Analysis of Jasper Therapeutics
Is Jasper Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.16 per share, a decrease this year of $0.94 per share, and a decrease next year of $0.02 per share.
Technical Analysis of Jasper Therapeutics
Should I short Jasper Therapeutics stock?
-
JSPR Moving Average Covergence Divergence (MACD) indicator is 1.4, suggesting Jasper Therapeutics is a Buy
-
Jasper Therapeutics Relative Strength Index (RSI) is 45.06, which suggest Jasper Therapeutics is oversold
-
The Bollinger Bands (25) for Jasper Therapeutics is (4.97 - 5.77), which suggest Jasper Therapeutics is a Sell
-
The Bollinger Bands (100) for Jasper Therapeutics is (4.48 - 5.94), which suggest Jasper Therapeutics is a Sell
* Jasper Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.